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Background. Malaria is a devastating disease, particularly in Africa, due to development of resistance by Plasmodium 
falciparum against all known antimalarial drugs, including artemisinin. Therefore, the search for new antimalarial drugs is 
urgently needed, especially drugs that can impede the heme detoxification pathway in the malaria parasite, a crucial 
requirement for parasite survival in host erythrocytes. 
Materials and Methods. Water infusions of Artemisia annua plants from two different origins, Cameroon and Luxembourg, 
were used in this study. A semi-quantitative in vitro method, based on the inhibition of ferriprotoporphyrin IX (FP) bio-
mineralisation developed by Deharo et al. [16], was used to reveal the differences in antimalarial activity of both plants. 
Reversed phase preparative liquid chromatography coupled to a photo diode array (PDA) detector was also used to test for 
differences in antimalarial activity. 
Results. Water extracts from the leaves of the Cameroon plant showed a higher potential antimalarial activity, represented 
by a higher ability to inhibit β-haematin formation in vitro than A. annua extracts from Luxembourg. Although extracts of 
the plants of both origins showed comparable efficiencies at high concentrations, the absorbance value at 405 nm of a 10% 
dilution of the Cameroon plant extract was 0.075, whereas it was 1.515 for the Luxembourg plant extract. The absorbance is 
inversely proportional to the antimalarial activity. According to the Prep-HPLC chromatogram of the Cameroon crude 
sample, seven major compounds at 325 nm were found. However, only four much less pronounced compounds appeared in 
the Luxembourg crude sample under the same chromatographic conditions and concentration. These were preliminarily 
identified as polyphenolic compounds.  
Conclusion. A. annua infusions are widely used by people who cannot afford other treatments. Depending on the cultivation 
locality different chemical profiles exist. This results in differences in hemozoin formation and will therefore also lead to 
alterations in antimalarial activity. 
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Abstract 
1 Introduction 
 
Malaria remains a serious global health problem, especial-
ly in developing countries, where children under the age of 
five and pregnant women are especially at risk [1]. The 
most important cause for this alarming situation is the rap-
id spread of malaria parasites that are resistant to anti-
malarial drugs currently used, including artemisinin. Hu-
man malaria is caused by one of four protozoa, Plasmodi-
um malariae, P. ovale, P. vivax and P. falciparum; the 
latter being the most important cause of morbidity and 
mortality [2]. 
During the intra-erythrocytic stage of the parasite life 
cycle, the growing parasite consumes the intercellular pro-
teins in red blood cells (RBCs), mainly haemoglobin, as a 
source of amino acids. Digestion of haemoglobin takes 
place inside the parasite food vacuoles, where the pH 
range is between 5.0 and 5.4 [3]. Massive degradation of 
haemoglobin leads to the generation of large amounts of 
free oxidized heme, which is extremely toxic to the para-
site, leading to damage of the parasite membrane due to 
oxidative stress. However, the malaria parasite has devel-
oped a unique mechanism for heme detoxification through 
its bio-mineralisation into an insoluble, inert, crystalline, 
black-brown pigment named hemozoin [4]. This prevents 
the accumulation of toxic free heme, thus making this pro-
cess crucial for parasite survival. Inhibition of hemozoin 
formation is considered to be the most suitable target to 
develop new anti-malarials. 
Hemozoin is a polymer made of dimers of haematin 
molecules that are connected by hydrogen bonds. These 
dimers are formed through an iron-oxygen coordinate 
bond that links the central ferric iron of one haematin to 
the carboxylate side group oxygen of another haematin [3-
7]. Several antimalarial drugs, such as chloroquine [3,5], 
are thought to exert their effect by complexing with free 
heme in the food vacuole, thus inhibiting its detoxification. 
A crystalline synthetic structure known as β-haematin, 
having the same linkage between the heme groups, is be-
lieved to be structurally, morphology and spectroscopical-
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ly identical to purified hemozoin [6]. β-haematin for-
mation could be accomplished in vitro under specific 
chemical conditions (acidic pH) through a bio-
crystallisation process, thus making it an outstanding tar-
get for in vitro screening of antimalarial compounds [8,9]. 
Natural products from medicinal plants continue to 
have an essential function in medicine and provide natural 
polytherapies. Most of the world’s population, mainly in 
developing countries, relies on natural products for medi-
cation. Due to a renewed interest and the growing use of 
medicinal plants, it is of great importance to study com-
monly used medicinal plants in detail. The genus Artemi-
sia, belonging to the Asteraceae family, is diverse and 
consists of about 400 species. Some very important drugs 
have been discovered from this genus, especially artemis-
inin, a secondary metabolite isolated from the Chinese 
herb A. annua. It was identified as a sesquiterpene lactone 
endoperoxide [10] and its derivatives have become the 
main weapon in the fight against malaria [11]. 
In continuation of our previous research on medicinal 
plants with antimalarial activity [12-15], we conducted a 
series of quantitative HPLC separations and studied the 
effect on hemozoin formation in order to explain the dif-
ferences in antimalarial activity of A. annua plants from 
two different origins: Cameroon and Luxembourg.  
 
2 Materials and Methods 
 
HPLC-grade glacial acetic acid, acetonitrile (ACN) and 
ethanol (EtOH) were all purchased from Merck 
(Germany). Dimethyl sulfoxide (DMSO), purity 99.5%, 
chloroquine diphosphate salt, sodium acetate, purity 99%, 
and haemin chloride were all obtained from Sigma-
Aldrich. 
  
2.1 Collection and extraction  
 
Samples of A. annua leaves were collected from Luxem-
bourg in 2012 and from Cameroon in 2009. The sample 
from Luxembourg was of the arteannuin-B type and the 
sample from Cameroon of the artemisinin type. Both 
plants were harvested at the early stages of flowering. 
Both cultivates were grown without inorganic fertilizer. 
Infusions were obtained by soaking 2 g of the plant 
material in 150 ml of distilled hot water at 90°C, left for 
20 minutes at room temperature, then filtered using MN 
615 Ø110 mm filter paper. Dried, concentrated extracts 
from the infusions were obtained by evaporation of the 
water at 60-70°C under reduced pressure using a rotary 
evaporator (IKA WEREKRV06-ML), followed by freeze-
drying (Labconco freeze drier) until a constant weight was 
achieved. The final dried extract was stored in opaque 
bottles and kept in desiccators until analysis by preparative 
HPLC. 
 
2.2 In   vitro  semi-quantitative   test  for 
  screening of anti-malarial activity  
 
Following the protocol by Deharo et al. [16], a mixture 
containing 50 μl of 0.5 mg/ml haemin chloride (freshly 
dissolved in DMSO), 100 μl of 0.5 M sodium acetate buff-
er (pH 4.4) and 50 μl of the tested anti-malarial drug solu-
tion or control, was incubated in a normal non-sterile 96-
well flat bottom plate at 37ºC for 18-24 hours. It is impera-
tive that the solutions be added to the plate in this order. 
The plate was then centrifuged for 10 minutes at 4000 
rpm. The supernatant was removed and the pH of reaction 
was measured. The final pH of the mixture should be be-
tween 5.0 and 5.2. The wells were washed with 200 μl 
DMSO per well to remove free haemin chloride. The plate 
was centrifuged again, discharging the supernatant after-
wards. The β-haematin remaining was then dissolved in 
200 μl of 0.1 M NaOH to form an FP that could be meas-
ured spectrophotometrically. Finally, the absorbance was 
determined at 405 nm using an ELISA reader (Stat Fax-
2100). Ultrapure water was used as negative control, 
whereas chloroquine dissolved in ultrapure water was used 
as positive control.  
 
2.3 Chromatographic analysis 
 
The Analytical High Pressure Liquid Chromatography 
(HPLC-PDA) system consists of an alliance 2695 HPLC, 
2996-Photo Diode Array (PDA). Data acquisition and con-
trol were carried out using Empower software (Waters, 
Germany). The Preparative High Pressure Liquid Chroma-
tography (Prep-HPLC-PDA) system consisted of a 3535 
quaternary gradient module, which provides a flow rate of 
up to 45 ml/min, equipped with 996 PDA detectors 
(Waters, Germany). 
The mobile phase was prepared by mixing acidic ultra-
purified water (containing 0.05% glacial acetic acid) with 
acetonitrile (ACN) in the gradient mode. The acidic water 
phase was filtered by using a 0.45 mm microporous filter 
and was degassed by sonication prior to use. The HPLC 
analytical experiments were run on an octadecylsilane C18 
chemically bonded column (Waters XBridge, 4.6 x 150 
mm, 5 μm). The flow rate was 1 ml/min. The injection 
volume was 10 ml of 2mg/ml of the dried extract. Anal-
yses were performed at room temperature. The mobile 
phase consisted of (A) 0.05% acetic acid in water and (B) 
ACN. The applied linear gradient was 90-0% A in 25 min. 
Before analysis, the column was equilibrated with the 
starting mixture for 10 minutes. A wavelength of 325 nm 
was chosen as it was found to be the most appropriate for 
the determination of all major separated peaks.  
The HPLC Preparative experiments were run on ODS 
column (Agilent PrepHT C18, 22.2 x 250 mm, 10 μm). 
The same mobile phase and gradient were used. The ap-
plied flow rate used was 20 ml/min and the injection vol-
ume was 1000 ml. Total run time of last eluting compound 
was about 10 minutes. 
Sample solutions were prepared by dissolving 50 mg 
of dry extract in 5 ml acidic water (0.05%), first by me-
chanical shaking for 3 min, followed by sonification for 1 
min. The obtained solution was filtered using a 0.45 mm 
membrane filter (PVDF) before injection into the Prep-
HPLC.  
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3 Results  
 
3.1 Influence on hemozoin formation  
 
Fig. 1 shows the inhibitory effect on hemozoin formation 
of different dilutions of A. annua tea infusion obtained on 
base of the Cameroon sample, while in Fig. 2 the test re-
sults after lyophilisation of the hot water tea infusion of 
the plant are expressed. According to the semi-quantitative 
method used in this research, the absorption is inversely 
proportional to the hemozoin content. The lower the ab-
sorption, the stronger the inhibitory effect towards hema-
zoin formation.  
These results can be compared with previously pub-
lished results [14] that had been obtained by using the 
same method and same plant species, but from a different 
origin (Luxembourg). Here, the potential antimalarial ac-
tivity, represented by the ability to inhibit β-haematin for-
mation, was lower compared with the Cameroon plant 
extracts. The absorbance at 405 nm of a 10% dilution of 
the Luxembourg plant was 1.515, whereas a value of 0.075 
was obtained for the same dilution of the Cameroon plant 
extract. This strong difference in activity may be attributed 
to differences in the amount of polyphenols in each plant 
sample and to the ability of these chemicals to form non-
covalent interactions (hydrogen bonding) with ferriheme. 
Table 1 summarises the results on β-haematin inhibitory 
effect of different dilutions of tea infusion from A. annua 
leaves obtained from the two different origins (Cameroon 
and Luxembourg). In addition, the effects measured with 
two other Artemisia species, A. afra and A. sieberi, are 
included.  
 
3.2 Chromatographic analysis 
 
An overlay of the results obtained with preparative HPLC 
of the concentrated extracts is shown in Fig. 3. One ml of 
this solution was directly injected into the preparative 
HPLC (10 mg each). Comparison of the Prep-HPLC com-
positional profiles disclosed a significant difference be-
tween the two selected extracts using the same concentra-
tion and experimental conditions accounting for their bio-
logical differences. The overlay of the UV-visible spectra 
of the major peaks obtained with the concentrated extract 
from the Cameroon sample mixture is shown in Fig. 4. 
Chromatogram differences of the extracts by the photodi-
ode array detector revealed that in addition to compounds 
in common, other metabolites were present in the water 
extracts sharing quite similar UV-Vis spectral absorbance. 
 
 
Figure 1. Efficiency of A. annua infusion from Cameroon com-
pared with the negative (water) and positive control (CQ-
chloroquine 0.1 mg/ml), showing the absorption values of dis-
solved β-haematin (alkaline haematin) at 405 nm. The absorption 
is inversely proportional to compound efficiency. Each result 
represents the average of 16 individual experiments.  
Figure 2. Efficiency  of A. annua lyophilised infusion from 
Cameroon, compared with the negative (water) and positive 
control (CQ-chloroquine 0.1 mg/ml), showing the absorption 
values of dissolved β-haematin (alkaline haematin) at 405 nm. 
The absorption is inversely proportional to compound efficiency. 
Each result represents the average of 16 individual experiments. 
Species and origin Absorption values at 405 nm for different dilutions 
100% 30% 10% 5% 
A. annua Cameroon 0.054 0.059 0.075 0.106 
A. annua Luxembourg 0.098 0.158 1.515 eq 
A. afra 0.125 0.109 0.263 0.600 
A. sieberi 0.106 0.142 1.732 eq 
 
 
Table 1. Efficiency of infusions of different Artemisia species, showing the absorption values of dissolved β-haematin (alkaline haema-
tin) at 405 nm. Each result represents the average of 16 individual experiments. 
eq: no significant difference compared with pure water 
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4 Discussion 
 
When comparing the in vitro activity of A. annua plant 
extracts of both origins, a higher activity of the Cameroon 
plant was observed for all concentrations tested. The soils 
of the two locations have been analysed by the Laboratoire 
de l’Institut Technique Agricole of Luxembourg and do 
not show striking differences or deficiencies in essential 
minerals. 
Conventionally, A. annua tea is considered a rich 
source of antioxidant phenolics (mainly flavonoids) and 
artemisinin [17,18] and it has been suggested that flavo-
noids and other substances present in the tea might im-
prove the efficacy of artemisinin [19]. 
In a previous study by Lehane et al. [20], 11 purified 
flavonoids from dietary sources were tested for their anti-
malarial activity in vitro against chloroquine-sensitive and 
chloroquine-resistant strains. The most effective flavo-
noids were shown to be luteolin and quercetin, followed 
by apigenin. 
A. annua cultivated in Cameroon has a different chemi-
cal proﬁle than the same plant being cultivated in Luxem-
bourg. This might be due to differing climatic conditions 
and other environmental inﬂuences. 
A typical Prep-HPLC chromatogram of the Cameroon 
concentrated sample revealed seven major compounds at 
325 nm (Fig. 3). However, four major, less pronounced, 
compounds appeared in the Luxembourg concentrated 
sample under the same chromatographic conditions and 
concentration. Only two major peaks share the same reten-
tion time in both samples, namely at 3.42 and 4.45 
minutes, respectively. They also showed the same UV-
visible spectra (Fig. 4). For some smaller peaks in the Lux-
embourg sample, a match in retention time was also found 
on 7.0, 7.5 and 8.5 min. On 6.25 min, a match for a small-
er peak of the Cameroon sample was observed.  
The UV-visible spectra of the peaks from the Came-
roon sample concentrated extract indicate that these peaks 
may correspond with polyphenolic compounds (Fig. 4). 
These compounds are rich in conjugated bounds and there-
fore show an absorption maximum at 325 nm. According 
to Fig. 3, the total amounts of compounds present were 
much higher in the Cameroon sample than in the Luxem-
bourg sample. It is striking that this also corresponds with 
an improved activity towards hemozoin formation ob-
served for the Cameroon sample. Over the years, several 
laboratories have made a comparative analysis of the Cam-
eroon and Luxembourg A. annua samples. 
A UPLC analysis run at the Celabor laboratory in 2010 
(P. Lutgen, pers. comm.) showed that a plant from Came-
roon contained twice as many flavonoids and polyphenols. 
It contained ten times more artemisinin (1.2%), three times 
as much scopoletin and four times more rutin. The sample 
from Luxembourg was, however, four times richer in 
chlorogenic acid. A qualitative froth test for saponins has 
been performed by P. Lutgen on samples from Luxem-
bourg and Cameroon. The latter samples are void of sapo-
nins, while those from Luxembourg yielded a strong froth. 
An extensive analysis of the essential oil present in A. an-
nua samples from Cameroon and Luxembourg was also 
run by R. C. Kengwe at the Laboratoire National de la 
Santé in Luxembourg in 2010. Although differences were 
found, they were not large enough to elaborate a working 
hypothesis. 
 
5 Conclusions 
 
Currently, there is an urgent need for antimalarial drugs 
due to the increasing spread of resistant strains. A. annua 
is a medicinal plant used in traditional Chinese medicine 
as herbal tea to treat malaria. A. annua plantations are 
widespread and remain the only hope for many people 
who cannot afford other treatments. A. annua cultivated in 
Cameroon by small farmers may have a different chemical 
proﬁle than plants cultivated in Luxembourg. This might 
be due to different genotypes of A. annua. Differences in 
climatic conditions and other environmental inﬂuences 
Figure 3. Overlay  of preparative HPLC chromatograms of 
Cameroon and Luxembourg crude mixtures. 
Figure 4. Overlay of UV-visible spectra of the major eluted 
peaks from the Cameroon crude mixture. 
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might also affect the inhibition efficiency. This probably 
leads to a higher antimalarial efficiency, as indicated by 
our results on the hemozoin inhibitory effect. Differences 
in the inhibitory effect of other Artemisia species on β-
haematin have also been observed, and HPLC analysis on 
these Artemisia species are planned by our group. 
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